English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1106]
News [2760]
Articles [185]
Editorials [9]
Conferences [110]
elearning [25]
Alternating pazopanib and bevacizumab shows promising activity in metastatic renal cell carcinoma
Alternating pazopanib and bevacizumab shows promising activity in metastatic renal cell carcinoma
Preoperative educational materials improve the short‐term quality of life of patients with urinary cancer
Preoperative educational materials improve the short‐term quality of life of patients with urinary cancer
Prostate Cancer Research and Macmillan Cancer Support unite to harness patient insight and health data to improve cancer care
Prostate Cancer Research and Macmillan Cancer Support unite to harness patient insight and health data to improve...
New anti-cancer strategy shows promise in preclinical studies
New anti-cancer strategy shows promise in preclinical studies
Research provides new biological and clinical insights for the development of personalized treatment strategies in metastatic prostate cancer
Research provides new biological and clinical insights for the development of personalized treatment strategies in...
New drug combination improves survival in patients with muscle-invasive bladder cancer
New drug combination improves survival in patients with muscle-invasive bladder cancer
Combining 2 VEGF-blocking targeted therapies significantly boosted survival in kidney cancer study
Combining 2 VEGF-blocking targeted therapies significantly boosted survival in kidney cancer study
Updated guideline on shorter-course radiation therapy for localised prostate cancer
Updated guideline on shorter-course radiation therapy for localised prostate cancer
FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations
FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate...
How have US diagnostic and treatment decisions for prostate cancer changed in recent years?
How have US diagnostic and treatment decisions for prostate cancer changed in recent years?
<12345…276>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top